Stockreport

Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders

APRICUS BIOSCIENCES  (APRI) 
Last apricus biosciences earnings: 11/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: apricusbio.com
PDF Transaction to result in Nasdaq-listed company focused on developing novel products to treat central nervous system diseasesTransaction expected to advance Seelos’ robus [Read more]